Evolus Income Statement 2025-2011 | EOLS

Brief overview of revenue and earnings at Evolus

The comparison covers a five-year financial horizon. Revenue at Evolus moved from 56.5 million dollars in 2020 to 297 million dollars in 2025. Overall revenue changed by +425.6%, equal to an annualized rate of about 39.4%. The annual growth rate indicates an exceptionally strong top-line trend.

Gross profit was 38.2 million dollars at the start and 197 million dollars at the end of the period (+415.4%). Direct costs outpaced revenue, limiting the benefit of changes in sales. Gross margin moved from 67.6% to 66.3%. The gross margin stayed within a similar range.

The operating result measured by EBITDA moved from −61.7 million dollars to −25.2 million dollars, or +59.2%. EBITDA underperformed the top-line trend. At the operating-margin level, the figure shifted from −109.1% to −8.5%. A wider margin confirms stronger operating efficiency.

Net income moved from −163 million dollars at the start to −51.6 million dollars at the end. Losses became smaller, but the business remains unprofitable.

Market capitalization changed from $228 million to $271 million (+19%). Capitalization grew more slowly than the underlying results.

What the figures show

The five-year picture requires weighing both strengths and weaknesses. The strongest signals are sales growth, improving net profitability and an improving EBITDA margin. The weaker side of the profile includes pressure from direct costs and a low EBITDA margin. Future reports should be judged by revenue momentum, margins, and the conversion of sales into net income.